Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (31-40 of 225) with videos related to

Pageof 23
Sort By:
Frontiers in Oral Health|November 25, 2022
Editorial: The interplay between the oral Microbiota and rheumatoid arthritisDaniel Manoil, Nagihan Bostanci, Axel Finckh
Revue Medicale Suisse|March 11, 2026
[Rheumatoid arthritis pathogenesis. From susceptibility to autoimmunity, and arthritis]Matthias Jarlborg, Cem Gabay, Axel Finckh
Revue Medicale De La Suisse Romande|November 24, 2004
[Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis]Axel Finckh, Cem Gabay, Pierre-André Guerne
Annals of Internal Medicine|March 3, 2010
Cost-effectiveness of biologics in early rheumatoid arthritisAxel Finckh, Nick Bansback, Matthew H Liang
Arthritis and Rheumatism|September 18, 2003
The exercise prescription in rheumatoid arthritis: primum non nocereAxel Finckh, Maura Iversen, Matthew H Liang
Nutrients|January 5, 2021
The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis DevelopmentDeshiré Alpízar-Rodríguez, Axel Finckh, Benoît Gilbert
Rheumatology (Oxford, England)|April 28, 2017
New viral outbreaks: time for rheumatologists to get involved?: Chronic arthralgias and viral infectionsAxel Finckh, Deshire Alpizar-Rodriguez, Ilias Lazarou
Rheumatology (Oxford, England)|April 30, 2015
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management RegistryCem Gabay, Myriam Riek, Almut Scherer, et al.
Frontiers in Oral Health|May 23, 2022
Periodontitis in First Degree-Relatives of Individuals With Rheumatoid Arthritis: A Short Narrative ReviewAlkisti Zekeridou, Benoit Gilbert, Axel Finckh, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
A systematic review of infliximab in the treatment of early rheumatoid arthritisSophie Martin Du Pan, Cem Gabay, Axel Finckh
Pageof 23

Showing results (31-40 of 225) with videos related to

Sort By:
Pageof 23
Frontiers in Oral Health|November 25, 2022
Editorial: The interplay between the oral Microbiota and rheumatoid arthritisDaniel Manoil, Nagihan Bostanci, Axel Finckh
Revue Medicale Suisse|March 11, 2026
[Rheumatoid arthritis pathogenesis. From susceptibility to autoimmunity, and arthritis]Matthias Jarlborg, Cem Gabay, Axel Finckh
Revue Medicale De La Suisse Romande|November 24, 2004
[Review of the protective effects of tumor necrosis factor inhibitors in rheumatoid arthritis]Axel Finckh, Cem Gabay, Pierre-André Guerne
Annals of Internal Medicine|March 3, 2010
Cost-effectiveness of biologics in early rheumatoid arthritisAxel Finckh, Nick Bansback, Matthew H Liang
Arthritis and Rheumatism|September 18, 2003
The exercise prescription in rheumatoid arthritis: primum non nocereAxel Finckh, Maura Iversen, Matthew H Liang
Nutrients|January 5, 2021
The Role of Nutritional Factors and Intestinal Microbiota in Rheumatoid Arthritis DevelopmentDeshiré Alpízar-Rodríguez, Axel Finckh, Benoît Gilbert
Rheumatology (Oxford, England)|April 28, 2017
New viral outbreaks: time for rheumatologists to get involved?: Chronic arthralgias and viral infectionsAxel Finckh, Deshire Alpizar-Rodriguez, Ilias Lazarou
Rheumatology (Oxford, England)|April 30, 2015
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management RegistryCem Gabay, Myriam Riek, Almut Scherer, et al.
Frontiers in Oral Health|May 23, 2022
Periodontitis in First Degree-Relatives of Individuals With Rheumatoid Arthritis: A Short Narrative ReviewAlkisti Zekeridou, Benoit Gilbert, Axel Finckh, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
A systematic review of infliximab in the treatment of early rheumatoid arthritisSophie Martin Du Pan, Cem Gabay, Axel Finckh
Pageof 23